Akemi Ishida-Yamamoto Selected Research

Collagen Type VII

12/2023	Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa.
11/2018	Mild dystrophic epidermolysis bullosa associated with homozygous gene mutation c.6216+5G>T in type VII collagen ultrastructurally suggestive of the decreased number of anchoring fibrils.
1/2018	Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis.
12/2016	Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
8/2010	Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.
1/2009	Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akemi Ishida-Yamamoto Research Topics

Disease

24	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022 - 12/2002
12	Neoplasms (Cancer) 04/2023 - 11/2003
8	Skin Diseases (Skin Disease) 06/2023 - 04/2005
6	Infections 01/2022 - 04/2003
6	Netherton Syndrome 11/2018 - 01/2005
5	Ichthyosis (Xeroderma) 01/2019 - 03/2003
5	Hypersensitivity (Allergy) 11/2018 - 04/2005
5	Inflammation (Inflammations) 01/2017 - 09/2005
4	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 12/2023 - 08/2010
4	Melanoma (Melanoma, Malignant) 04/2023 - 01/2017
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2015 - 11/2003
3	Wounds and Injuries (Trauma) 11/2022 - 05/2006
3	Vasculitis (Vasculitides) 02/2021 - 12/2018
3	Alopecia (Baldness) 10/2018 - 05/2008
3	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 08/2018 - 02/2005
3	Dermatitis 04/2018 - 10/2013
3	Hypohidrosis 08/2017 - 09/2015
2	Blister (Bulla) 12/2023 - 08/2010
2	Autoimmune Diseases (Autoimmune Disease) 06/2023 - 01/2018
2	Rheumatoid Arthritis 01/2023 - 05/2010
2	Bullous Pemphigoid (Pemphigoid) 01/2022 - 10/2012
2	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 10/2012
2	Arteritis 03/2021 - 09/2014
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 12/2018
2	Thrombosis (Thrombus) 02/2020 - 12/2018
2	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2019 - 08/2005
2	Adenocarcinoma 08/2017 - 11/2003
2	Urticaria (Hives) 08/2017 - 03/2017
2	Lichen Planus (Lichen Ruber Planus) 06/2017 - 07/2011
2	Diffuse Palmoplantar Keratoderma (Tylosis) 01/2017 - 08/2014
2	Necrosis 05/2015 - 07/2007
2	Fever (Fevers) 09/2014 - 04/2005
2	Atopic Dermatitis (Atopic Eczema) 11/2013 - 07/2011
2	Primary Cutaneous Anaplastic Large Cell Lymphoma 09/2013 - 11/2008
2	Mycosis Fungoides 09/2013 - 12/2010
2	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 10/2010 - 02/2002
2	Crohn Disease (Crohn's Disease) 05/2010 - 07/2007
2	Darier Disease (Darier's Disease) 08/2006 - 08/2004
1	Annular Erythema 06/2023
1	COVID-19 06/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2002
7	Peptide Hydrolases (Proteases)FDA Link 04/2018 - 01/2005
6	Collagen Type VIIIBA 12/2023 - 01/2009
5	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 04/2003
5	Keratins (Keratin)IBA 12/2020 - 02/2002
4	loricrinIBA 01/2019 - 02/2003
4	CytokinesIBA 07/2018 - 07/2009
4	Desmoglein 1IBA 04/2018 - 01/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 07/2007
3	Differentiation AntigensIBA 04/2023 - 04/2004
3	Interleukin-8 (Interleukin 8)IBA 07/2018 - 07/2009
3	Interleukin-17 (Interleukin 17)IBA 07/2018 - 10/2011
3	Carcinoembryonic AntigenIBA 08/2017 - 09/2015
3	Kallikreins (Kallikrein)IBA 01/2017 - 02/2007
3	Filaggrin ProteinsIBA 11/2013 - 02/2002
3	Infliximab (Remicade)FDA Link 01/2013 - 07/2007
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2006 - 11/2003
3	Photosensitizing Agents (Photosensitizers)IBA 11/2006 - 11/2003
2	Messenger RNA (mRNA)IBA 06/2023 - 12/2013
2	Janus Kinase InhibitorsIBA 01/2023 - 01/2023
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2018
2	Colchicine FDA LinkGeneric 02/2021 - 09/2014
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 12/2018
2	Imatinib Mesylate (Gleevec)FDA Link 06/2020 - 03/2015
2	AntibodiesIBA 06/2020 - 01/2013
2	AllergensIBA 11/2018 - 05/2014
2	EnzymesIBA 10/2018 - 03/2013
2	Interleukin-22 (IL-22)IBA 07/2018 - 06/2013
2	Imiquimod (Aldara)FDA LinkGeneric 07/2018 - 11/2015
2	Interleukin-6 (Interleukin 6)IBA 07/2018 - 07/2009
2	Protease Inhibitors (Protease Inhibitor)IBA 04/2018 - 07/2006
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 09/2015
2	Cholinergic Agents (Cholinergics)IBA 08/2017 - 03/2017
2	AutoantibodiesIBA 06/2017 - 10/2012
2	Cholecalciferol (Vitamin D3)FDA Link 12/2016 - 02/2003
2	Ointments (Pastes)IBA 12/2016 - 06/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2015 - 05/2012
2	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 04/2011
2	TransglutaminasesIBA 08/2014 - 04/2004
2	matriptaseIBA 05/2014 - 03/2007
2	Nonsense Codon (Nonsense Mutation)IBA 11/2013 - 05/2008
2	Cadherins (E-Cadherin)IBA 09/2013 - 07/2006
2	calcipotriene (calcipotriol)FDA LinkGeneric 06/2013 - 02/2003
2	ResistinIBA 06/2013 - 03/2013
2	Keratin-1IBA 08/2011 - 03/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2009 - 01/2002
2	Serine Proteases (Serine Protease)IBA 03/2007 - 02/2007
2	Keratin-14 (Keratin 14)IBA 10/2006 - 12/2002
2	Adenosine Triphosphatases (ATPase)IBA 08/2006 - 08/2004
2	involucrinIBA 09/2005 - 04/2004
2	Peptides (Polypeptides)IBA 12/2002 - 02/2002
1	Interferon Type IIBA 06/2023
1	SS-B antibodiesIBA 06/2023

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2003
3	Drug Therapy (Chemotherapy) 12/2010 - 12/2007
3	Photochemotherapy (Photodynamic Therapy) 11/2006 - 11/2003
2	Immunotherapy 01/2023 - 06/2020
2	Lymph Node Excision (Lymph Node Dissection) 07/2020 - 08/2016
2	Radiotherapy 12/2010 - 03/2005
2	Transplantation 12/2010 - 08/2010